Antimicrobial synergism in the therapy of gram-negative rod bacteremia
- PMID: 412648
- DOI: 10.1159/000237759
Antimicrobial synergism in the therapy of gram-negative rod bacteremia
Abstract
To determine if antimicrobial synergism might affect the results of treatment of gram-negative rod infections, 444 bacteremias from 1972 through 1974 were studied. On these, 173 were treated with two antibiotics to which the infecting organisms were sensitive. Clinical responses were observed in 80% of 83 cases where antibiotic activity was synergistic, as defined by a minimum inhibitory concentration (MIC) of each antibiotic in combination being one-fourth or less than the MICs of individual drugs. This response rate was significantly better than the 64% response seen in patients treated with nonsynergistic combinations (p less than 0.05). Synergism correlated with significantly better clinical responses in those patients with "rapidly fatal" and "ultimately fatal" underlying disease (p less than 0.005), neutropenia (p less than 0.001), shock (p less than 0.01) and Pseudomonas aeruginosa infections (p less than 0.05). These results suggest that the use of antibiotic combinations to treat patients with gram-negative rod bacteremia who have the poorest prognosis is clinically justified and the improved results may be related to the synergistic activity of antimicrobial agents.
Similar articles
-
Clinical and laboratory studies with tobramycin.Chemotherapy. 1974;20(4):245-56. doi: 10.1159/000221814. Chemotherapy. 1974. PMID: 4212996 Clinical Trial. No abstract available.
-
Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.J Lab Clin Med. 1975 Nov;86(5):853-62. J Lab Clin Med. 1975. PMID: 810533
-
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].Jpn J Antibiot. 2006 Jun;59(3):177-200. Jpn J Antibiot. 2006. PMID: 16913404 Japanese.
-
Antibiotic use in neonatal sepsis.Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.
-
Newer antibiotic agents acting on gram-negative organisms.Geriatrics. 1973 Aug;28(8):72-6. Geriatrics. 1973. PMID: 4212199 Review. No abstract available.
Cited by
-
Combination therapy for treatment of infections with gram-negative bacteria.Clin Microbiol Rev. 2012 Jul;25(3):450-70. doi: 10.1128/CMR.05041-11. Clin Microbiol Rev. 2012. PMID: 22763634 Free PMC article. Review.
-
Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia.BMC Infect Dis. 2012 Nov 16;12:308. doi: 10.1186/1471-2334-12-308. BMC Infect Dis. 2012. PMID: 23157735 Free PMC article.
-
New developments in the treatment of gram-negative bacteremia.West J Med. 1986 Feb;144(2):185-94. West J Med. 1986. PMID: 3513451 Free PMC article. Review.
-
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.BMC Infect Dis. 2014 Mar 24;14:161. doi: 10.1186/1471-2334-14-161. BMC Infect Dis. 2014. PMID: 24655422 Free PMC article.
-
Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies.Exp Ther Med. 2018 Mar;15(3):2418-2428. doi: 10.3892/etm.2018.5727. Epub 2018 Jan 9. Exp Ther Med. 2018. PMID: 29456647 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources